文献速递生殖医学

宫腔镜联合子宫输卵管超声造影在宫腔内人工授精中的应用及妊娠结局分析

[Application and pregnancy outcomes analysis of hysteroscopy combined with hysterosalpingo-contrast sonography in intrauterine insemination].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2025-01-01

回顾性分析北京大学第三医院385例宫腔镜检查后6个月内行首次供精人工授精患者的临床资料,比较宫腔镜联合四维子宫输卵管超声造影组(213例)与单独宫腔镜组(172例)的妊娠结局。联合组临床妊娠率24.9%、活产率21.1%,均显著高于单独宫腔镜组的15.1%和12.8%(P均<0.05)。多因素分析显示双次授精提高临床妊娠率(OR=2.42),输卵管通畅性检查至授精间隔>6个月为危险因素(OR=0.35)。

要点

  • 宫腔镜联合四维子宫输卵管超声造影组临床妊娠率24.9%(53/213)、活产率21.1%(45/213),均显著高于单独宫腔镜组。
  • 双次授精较单次授精可显著提高临床妊娠率(OR=2.42,95%CI 1.02~5.72;P=0.044)。
  • 输卵管通畅性检查至人工授精间隔>6个月是临床妊娠的危险因素(OR=0.35,95%CI 0.14~0.92;P=0.047)。

核心结论

  • 宫腔镜检查联合子宫输卵管超声造影可安全、高效完成不孕症患者的生育力评估,有助于提高宫腔内人工授精的临床妊娠率和活产率。

研究设计与样本

  • 回顾性分析2020年10月1日至2022年9月30日北京大学第三医院妇产科生殖医学中心行宫腔镜检查、并在检查后6个月内接受第1周期供精人工授精治疗的385例患者的临床资料。

主要发现

  • 宫腔镜+4D-HyCoSy组临床妊娠率24.9%(53/213)、活产率21.1%(45/213),均显著高于宫腔镜组的15.1%(26/172)和12.8%(22/172)(P均<0.05)。
  • 两组间输卵管通畅程度无显著差异(P>0.05)。
  • 宫腔镜组输卵管通畅性检查至人工授精间隔时间中位数4.0个月,显著长于宫腔镜+4D-HyCoSy组的2.0个月(P<0.001)。
  • 双次授精较单次授精可显著提高临床妊娠率(OR=2.42,95%CI为1.02~5.72;P=0.044)。
  • 输卵管通畅性检查至人工授精间隔时间>6个月是临床妊娠的危险因素(OR=0.35,95%CI为0.14~0.92;P=0.047);宫腔镜检查至人工授精间隔时间、宫腔镜检查中所见及病理检查结果对临床妊娠率均无显著影响(P均>0.05)。

临床怎么用

  • 对于可疑子宫内膜或宫腔异常者,建议积极行宫腔镜检查。
  • 若既往未行输卵管通畅性评估或评估时间已超过半年,可同时联合进行宫腔镜检查和子宫输卵管超声造影,以提高临床妊娠机会。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To compare pregnancy outcomes between patients undergoing combined hysteroscopy and hysterosalpingo-contrast sonography (HyCoSy) versus hysteroscopy alone prior to intrauterine insemination, and to evaluate the safety and clinical value of the combined procedure in the diagnosis and treatment of infertility. Methods: A retrospective analysis was conducted on clinical data from 385 patients who underwent hysteroscopy at Peking University Third Hospital between October 1, 2020 and September 30, 2022, and subsequently received their first cycle of artificial insemination with donor sperm (AID) within six months. Pregnancy outcomes were compared between the group receiving combined hysteroscopy with four-dimensional HyCoSy (hysteroscopy+4D-HyCoSy group) and the group receiving hysteroscopy alone (hysteroscopy group). Multivariate logistic regression was used to analyze factors influencing pregnancy outcomes after AID. Results: Among the 385 patients included, 79 achieved clinical pregnancy. The clinical pregnancy rate (24.9%, 53/213) and live birth rate (21.1%, 45/213) in the hysteroscopy+4D-HyCoSy group were significantly higher than those in the hysteroscopy group [15.1% (26/172) and 12.8% (22/172), respectively; all P<0.05]. There was no significant difference in tubal patency between the two groups (P>0.05); however, the time interval from tubal patency assessment to intrauterine insemination was significantly longer in the hysteroscopy group compared to the hysteroscopy+4D-HyCoSy group (median: 4.0 vs 2.0 months; P<0.001). Multivariate analysis showed that double insemination significantly increased clinical pregnancy rate compared to single insemination (OR=2.42, 95%CI: 1.02-5.72; P=0.044). An interval exceeding 6 months between tubal patency assessment and intrauterine insemination was identified as a risk factor for reduced clinical pregnancy (OR=0.35, 95%CI: 0.14-0.92; P=0.047). Additionally, neither the time interval from hysteroscopy to intrauterine insemination nor hysteroscopic findings and pathological diagnoses had significant effects on clinical pregnancy rates (all P>0.05). Conclusions: The combination of hysteroscopy and HyCoSy provides a safe and efficient approach for fertility assessment in infertile patients and improves clinical pregnancy rate and live birth rate in intrauterine insemination cycles. Hysteroscopy is recommended for patients with suspected endometrial or intrauterine abnormalities. If no previous tubal patency assessment has been performed or the last assessment was more than six months prior, combined hysteroscopy and HyCoSy may be considered to enhance the likelihood of clinical pregnancy. 目的: 比较宫腔内人工授精治疗前应用宫腔镜检查联合子宫输卵管超声造影与单独应用宫腔镜检查的不孕症患者的妊娠结局,探索该联合评估策略在不孕症诊疗中的安全性和临床价值。 方法: 回顾性分析2020年10月1日至2022年9月30日北京大学第三医院妇产科生殖医学中心行宫腔镜检查、并在检查后6个月内接受第1周期供精人工授精治疗的385例患者的临床资料,比较宫腔镜检查联合四维子宫输卵管超声造影(即宫腔镜+4D-HyCoSy组)与单独宫腔镜检查(即宫腔镜组)两组患者的妊娠结局,并通过多因素logistic回归分析供精人工授精妊娠结局的影响因素。 结果: 共纳入385例患者,其中宫腔镜+4D-HyCoSy组213例、宫腔镜组172例,最终共79例获得临床妊娠;宫腔镜+4D-HyCoSy组患者的临床妊娠率(24.9%,53/213)和活产率(21.1%,45/213)均显著高于宫腔镜组[15.1%(26/172)和12.8%(22/172)],两组分别比较,差异均有统计学意义(P均<0.05)。两组间输卵管通畅程度无显著差异(P>0.05),但宫腔镜组患者的输卵管通畅性检查至人工授精间隔时间显著长于宫腔镜+4D-HyCoSy组(中位数分别为4.0和2.0个月;P<0.001)。多因素分析显示,双次授精较单次授精可显著提高临床妊娠率(OR=2.42,95%CI为1.02~5.72;P=0.044),输卵管通畅性检查至人工授精间隔时间>6个月是临床妊娠的危险因素(OR=0.35,95%CI为0.14~0.92;P=0.047),但宫腔镜检查至人工授精间隔时间、宫腔镜检查中所见及病理检查结果对临床妊娠率均无显著影响(P均>0.05)。 结论: 宫腔镜检查联合子宫输卵管超声造影可安全、高效完成不孕症患者的生育力评估,有助于提高宫腔内人工授精的临床妊娠率和活产率。对于可疑子宫内膜或宫腔异常者,建议积极行宫腔镜检查;若既往未行输卵管通畅性评估或评估时间已超过半年,可同时联合进行宫腔镜检查和子宫输卵管超声造影,以提高临床妊娠机会。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Liang L, Yang S, Wang LY, et al. [Application and pregnancy outcomes analysis of hysteroscopy combined with hysterosalpingo-contrast sonography in intrauterine insemination]. Zhonghua Fu Chan Ke Za Zhi. 2025. PMID: 41167777. doi:10.3760/cma.j.cn112141-20250416-00151

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。